Dr. Jur Strobos is a partner in the Firm's Healthcare and Intellectual Property practices in Washington, DC. He has extensive experience in providing legal and regulatory support, problem-solving, and strategic advice for US and international life science companies. Dr. Strobos has previously worked with an American law and lobbying firm where he supported clients for the last 20 years, except for a two-year period in which he did charitable work under a grant from the Bill and Melinda Gates Foundation. He also teaches a graduate course on drug development at the University of California, Berkeley.

Dr. Strobos provides legal, regulatory and policy advice to companies whose products are directly or indirectly regulated by the US Food and Drug Administration. He assists in a range of issues from enforcement and best practices to marketing authorization. He has guided many products through the FDA regulatory processes on behalf of clients. Dr. Strobos also advises US companies on comparable EU directives both in terms of application to their products, interplay with US regulations and accompanying strategies for product approval and marketing. He assists with inspectional readiness, compliance agreements, delegation subcontracts with clinical sites, research and manufacturing organizations. Additional areas of expertise include advising on Sunshine Act, False Claims Act, fraud and abuse, and compliance with securities regulations.